Panacea Biotec [PANACEABIO] vs Titan Bio-Tech [TITANBIO] Detailed Stock Comparison

Panacea Biotec Ltd.

NSE
Loading...

Titan Bio-Tech Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Panacea Biotec Ltd. wins in 5 metrics, Titan Bio-Tech Ltd. wins in 13 metrics, with 0 ties. Titan Bio-Tech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Panacea Biotec Ltd. Titan Bio-Tech Ltd. Better
P/E Ratio (TTM) 182.62 74.64 Titan Bio-Tech Ltd.
Price-to-Book Ratio 2.65 12.19 Panacea Biotec Ltd.
Debt-to-Equity Ratio 2.79 5.32 Panacea Biotec Ltd.
PEG Ratio -15.02 -1.22 Titan Bio-Tech Ltd.
EV/EBITDA -65.87 61.34 Titan Bio-Tech Ltd.
Profit Margin (TTM) -1.29% 14.13% Titan Bio-Tech Ltd.
Operating Margin (TTM) 1.99% 16.92% Titan Bio-Tech Ltd.
EBITDA Margin (TTM) 1.99% 16.92% Titan Bio-Tech Ltd.
Return on Equity -1.01% 14.04% Titan Bio-Tech Ltd.
Return on Assets (TTM) -0.65% 12.32% Titan Bio-Tech Ltd.
Free Cash Flow (TTM) $-776.74M $106.79M Titan Bio-Tech Ltd.
Dividend Yield N/A 0.42% N/A
1-Year Return 18.85% 419.45% Titan Bio-Tech Ltd.
Price-to-Sales Ratio (TTM) 3.61 10.54 Panacea Biotec Ltd.
Enterprise Value $19.26B $20.35B Titan Bio-Tech Ltd.
EV/Revenue Ratio 3.18 10.57 Panacea Biotec Ltd.
Gross Profit Margin (TTM) 58.88% N/A N/A
Revenue per Share (TTM) $99 $47 Panacea Biotec Ltd.
Earnings per Share (Diluted) $-1.28 $6.58 Titan Bio-Tech Ltd.
Beta (Stock Volatility) 0.14 -0.48 Titan Bio-Tech Ltd.

Panacea Biotec Ltd. vs Titan Bio-Tech Ltd. Stock Performance Analysis

Loading Price Chart...

PANACEABIO
TITANBIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Panacea Biotec Ltd.0.90%-2.19%39.94%70.71%51.42%43.20%
Titan Bio-Tech Ltd.0.80%3.09%-1.02%28.03%96.24%110.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Panacea Biotec Ltd.18.85%307.76%44.67%440.21%276.43%141.23%
Titan Bio-Tech Ltd.419.45%756.94%499.88%6,742.31%9,962.22%20,395.39%

Performance & Financial Health Analysis: Panacea Biotec Ltd. vs Titan Bio-Tech Ltd.

MetricPANACEABIOTITANBIO
Market Information
Market Cap i₹21.84B₹19.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i168,21168,890
90 Day Avg. Volume i144,184156,601
Last Close₹540.80₹448.30
52 Week Range₹292.40 - ₹647.00₹74.73 - ₹555.65
% from 52W High-16.41%-19.32%
All-Time High₹647.00 (Jun 09, 2026)₹1,460.00 (Feb 18, 2026)
% from All-Time High-16.41%-69.29%
Growth Metrics
Quarterly Revenue Growth0.01%0.48%
Quarterly Earnings Growth-0.12%0.94%
Financial Health
Profit Margin (TTM) i-0.01%0.14%
Operating Margin (TTM) i0.02%0.17%
Return on Equity (TTM) i-0.01%0.14%
Debt to Equity (MRQ) i2.795.32
Cash & Liquidity
Book Value per Share (MRQ)₹134.77₹40.29
Cash per Share (MRQ)₹13.86₹0.87
Operating Cash Flow (TTM) i₹-1,511,860,000₹197.75M
Levered Free Cash Flow (TTM) i₹-83,700,000₹215.32M
Dividends
Last 12-Month Dividend Yield iN/A0.42%
Last 12-Month Dividend i₹0.00₹4.00

Valuation & Enterprise Metrics Analysis: Panacea Biotec Ltd. vs Titan Bio-Tech Ltd.

MetricPANACEABIO (Apr 24, 2026)TITANBIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i182.6274.64
Forward P/E iN/AN/A
PEG Ratio i-15.02-1.22
Price to Sales (TTM) i3.6110.54
Price to Book (MRQ) i2.6512.19
Market Capitalization
Market Capitalization i₹21.84B₹19.90B
Enterprise Value i₹19.26B₹20.35B
Enterprise Value Metrics
Enterprise to Revenue i3.1810.57
Enterprise to EBITDA i-65.8761.34
Risk & Other Metrics
Beta i0.14-0.48
Book Value per Share (MRQ) i₹134.77₹40.29

Financial Statements Comparison: Panacea Biotec Ltd. vs Titan Bio-Tech Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPANACEABIO (2025)TITANBIO (2025)
Revenue/Sales i4.93B1.56B
Cost of Goods Sold i2.36B892.53M
COGS % of Revenue i47.9%57.0%
Gross Profit i2.57B671.98M
Gross Margin i52.1%43.0%
Research & Development iN/AN/A
Operating Income (EBIT) i-556.12M212.57M
Operating Margin i-11.3%13.6%
EBITDA i-76.28M285.61M
EBITDA Margin i-1.5%18.3%
Pre-Tax Income i-79.48M243.67M
Pre-Tax Income % of Revenue i-1.6%15.6%
Income Tax i7.71M60.96M
Income Tax % of Revenue i0.2%3.9%
Net Income (Profit) i-87.19M215.32M
Profit Margin i-1.8%13.8%

Balance Sheet & Liquidity Metrics

MetricPANACEABIO (2025)TITANBIO (2025)
Cash & Equivalents i821.25M51.28M
Total Current Assets i5.45B790.38M
Total Current Assets % of Revenue i110.7%50.5%
Total Current Liabilities i3.67B177.36M
Total Current Liabilities % of Revenue i74.5%11.3%
Long-Term Debt i150.00M4.19M
Long-Term Debt % of Revenue i3.0%0.3%
Total Shareholders Equity i8.31B1.53B
Retained Earnings i7.80B1.36B
Retained Earnings % of Revenue i158.3%87.0%
Property, Plant & Equipment i5.43B571.62M

Cash Flow Statement Comparison

MetricPANACEABIO (2025)TITANBIO (2025)
Operating Cash Flow i-1.51B197.75M
Operating Cash Flow % of Revenue i-30.7%12.6%
Capital Expenditures i-497.30M-85.26M
Free Cash Flow i-776.74M106.79M
FCF Margin i-15.8%6.8%
Debt Repayment i0-2.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPANACEABIOTITANBIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.25M41.32M
Float Shares i15.42M13.13M
% Held by Insiders i72.65%68.21%
% Held by Institutions i0.13%0.00%
% Held by Public i27.22%31.79%

Dividend Analysis & Yield Comparison: Panacea Biotec Ltd. vs Titan Bio-Tech Ltd.

MetricPANACEABIOTITANBIO
Last 12-Month Dividend i₹0.00₹4.00
Last 12-Month Dividend Yield iN/A0.42%
3-Year Avg Annual Dividend i₹0.00₹1.93
3-Year Avg Dividend Yield iN/A0.34%
3-Year Total Dividends i₹0.00₹5.80
Ex-Dividend DateN/ASep 19, 2025